Posted on 10/03/2021 10:24:31 AM PDT by Blood of Tyrants
The immune systems of the vast majority of people who have been infected with the CCP virus will continue to carry antibodies against the virus for at least 12 months, according to a peer-reviewed study accepted by the European Journal of Immunology on Sept. 24.
Scientists at the Finnish Institute for Health and Welfare studied the presence of antibodies in 1,292 subjects after eight months of infection. They found that 96 percent of the subjects still carried neutralizing antibodies and 66 percent still carried a type of antibody called nucleoprotein IgG.
The scientists then investigated antibody levels one year after infection by randomly selecting 367 subjects from the original cohort who had not yet been vaccinated. Eighty-nine percent of the subjects still carried neutralizing antibodies, and 36 percent still carried the IgG antibody.
Antibody levels were higher in subjects who experienced severe COVID-19 disease. Compared to those who had mild disease, these subjects had two to seven times as many antibodies for at least 13 months after infection.
(Excerpt) Read more at theepochtimes.com ...
I think while patents exist medicine will not progress as it could. They direct money to research of drugs that can be patented. This reduces money for research on natural things. Natural things are more likely to solve problems.
Patents encourage scientists to slightly modify a natural substance and stupidly advise people to use the modified version.
Here you go: https://www.t-detect.com/
The way it works is you register and pay on line, receive a confirmation along with an appointment slip for Labcorp (over email), they take two vials of blood and you get the results within 3-4 days over email.
Good luck!
Thanks!
Woo-hoo! I’ll drink to that. :-)
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.